scholarly journals Establishing consensus on ethics, traceability and biovigilance for medical products of human origin

2021 ◽  
Vol 99 (12) ◽  
pp. 907-909
Author(s):  
Paul Ashford ◽  
Jeremy Chapman ◽  
Martin Hildebrandt ◽  
Luc Noël ◽  
Timothy Pruett ◽  
...  
Keyword(s):  
Human Origin ◽  
Medical Products

scholarly journals Biovigilance for the Quality and Safety of Medical Products of Human Origin

2018 ◽  
Vol 10 (12) ◽  
pp. 857-867
Author(s):  
Vasiliki Gkioka ◽  
Panagiotis Tsirigotis ◽  
Markos Sarris ◽  
Sotiris Soulis ◽  
Athanasios Apostolou ◽  
...  
Keyword(s):  
Quality And Safety ◽  
Human Origin ◽  
Medical Products

scholarly journals ISBT 128 Standard for Coding Medical Products of Human Origin

2017 ◽  
Vol 44 (6) ◽  
pp. 386-390 ◽  
Author(s):  
Paul Ashford ◽  
Matthew Delgado
Keyword(s):  
Human Origin ◽  
Medical Products ◽  
Isbt 128

Ethical aspects of medical products of human origin

2016 ◽  
Vol 12 (1) ◽  
pp. 281-287
Author(s):  
D. E. Martin
Keyword(s):  
Human Origin ◽  
Ethical Aspects ◽  
Medical Products

scholarly journals Globally consistent coding systems for medical products of human origin

2013 ◽  
Vol 91 (5) ◽  
pp. 314-314A ◽  
Author(s):  
Ruth M Warwick ◽  
Jeremy Chapman ◽  
Timothy L Pruett ◽  
Haibo Wang
Keyword(s):  
Human Origin ◽  
Medical Products ◽  
Coding Systems

scholarly journals Vigilance for Medical Products of Human Origin—Progress on the Notify Library’s Global Effort to Share Information and Learning

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Evangelia Petrisli ◽  
Claudia Carella ◽  
Aurora Navarro ◽  
Deirdre Fehily ◽  
D. Michael Strong ◽  
...  
Keyword(s):  
Human Origin ◽  
Medical Products ◽  
Share Information

The Effect of Several Tissue Thromboplastins on the Activation of the Abnormal Factor X (Factor X Friuli)

1972 ◽  
Vol 27 (03) ◽  
pp. 535-542 ◽  
Author(s):  
A Girolami ◽  
M Lazzarin ◽  
G Molaro
Keyword(s):  
Prothrombin Time ◽  
Rabbit Brain ◽  
Factor X ◽  
Dilution Curve ◽  
Human Origin ◽  
Rabbit Lung ◽  
Normal Ratio

SummaryThe effect of several tissue thromboplastins on the abnormal factor X (factor X Friuli) has been investigated.The prothrombin time varied between 33.6 and 69 sec. The prothrombin time percentile values (saline dilution curve and Quick’s formula for citrated plasma) varied between 6.6 and 22% and between 10.9 and 32.8%, respectively. The prothrombin time patient/normal ratio varied between 2.24 and 4.43.The factor X level varied between 3.5 and 20% of normal.Significant correlations were found to exist between the percentile factor X level and the prothrombin time in seconds, the percentile prothrombin time values and the prothrombin time patient/normal ratio. Thromboplastins of human origin yielded the lowest factor X values namely 5% thereby appearing to be practically “inert” with regard to the abnormal factor X. Thromboplastins obtained from rabbit lung on the contrary yielded the highest values, namely 15.3%. Thromboplastins obtained from simian or rabbit brain gave values intermediate between these two extremes.

OVARIAN ASCORBIC ACID DEPLETION TEST FOR LUTEINIZING HORMONE

1967 ◽  
Vol 56 (4) ◽  
pp. 619-625 ◽  
Author(s):  
Hans Jacob Koed ◽  
Christian Hamburger
Keyword(s):  
Ascorbic Acid ◽  
Luteinizing Hormone ◽  
Dose Response ◽  
Response Curve ◽  
Dose Response Curve ◽  
Human Origin ◽  
Response Curves ◽  
Significant Difference ◽  
The Mean ◽  
Different Levels

ABSTRACT Comparison of the dose-response curves for LH of ovine origin (NIH-LH-S8) and of human origin (IRP-HMG-2) using the OAAD test showed a small, though statistically significant difference, the dose-response curve for LH of human origin being a little flatter. Two standard curves for ovine LH obtained with 14 months' interval, were parallel but at different levels of ovarian ascorbic acid. When the mean ascorbic acid depletions were calculated as percentages of the control levels, the two curves for NIH-LH-S8 were identical. The use of standards of human origin in the OAAD test for LH activity of human preparations is recommended.

Infections caused by medical products at longterm nursing care

2020 ◽  
pp. 7-10
Author(s):  
Hardy Thorsten Panknin
Keyword(s):  
Nursing Care ◽  
Nursing Staff ◽  
Nosocomial Infections ◽  
The Elderly ◽  
Relevant Information ◽  
Medical Products ◽  
The Disabled ◽  
The Usa ◽  
Therapeutic Measures

Nosocomial infections in the elderly, often suffering from many ailments, patients in homes for the disabled and the old are among the problematic diseases that specialized nursing staff and doctors have to deal with more often in such institutions. Review work from the USA introduces relevant information about infectious risks, as well as possible preventive and therapeutic measures.

Sign in / Sign up

Export Citation Format

Share Document